| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9743 |
| Human Intestinal Absorption | HIA+ | 0.9906 |
| Caco-2 Permeability | Caco2+ | 0.7086 |
| P-glycoprotein Substrate | Non-substrate | 0.8415 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9727 |
| Non-inhibitor | 0.9836 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9154 |
| Distribution |
| Subcellular localization | Lysosome | 0.6296 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7952 |
| CYP450 2D6 Substrate | Non-substrate | 0.8412 |
| CYP450 3A4 Substrate | Non-substrate | 0.7909 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8906 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9500 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9695 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9675 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9845 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9133 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9482 |
| Non-inhibitor | 0.9717 |
| AMES Toxicity | Non AMES toxic | 0.9601 |
| Carcinogens | Carcinogens | 0.6890 |
| Fish Toxicity | Low FHMT | 0.6099 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.6878 |
| Honey Bee Toxicity | High HBT | 0.8156 |
| Biodegradation | Ready biodegradable | 0.6368 |
| Acute Oral Toxicity | III | 0.7121 |
| Carcinogenicity (Three-class) | Non-required | 0.5026 |